Anixa Biosciences is trading at $3.00 (12% down) as the stock reverses a sharp, largely unexplained pre-market jump seen on August 03, 2026.

  • The move appears to be a pullback from prior speculative or sentiment-driven buying rather than a new fundamental shift, as there is no fresh company-specific news.
  • The decline is idiosyncratic rather than macro-driven, given that broader U.S. indices are trading slightly higher in the pre-market session.